Hi @Wesvv11,. Thank you for sharing your thoughts and ideas.

06 Feb 2023, 09:43

Hi @Wesvv11, Thank you for sharing your thoughts and ideas. We highly appreciate you taking the time to verbalise your concerns and are happy to address these topics. We are indeed putting a lot of focus and effort on onboarding new clinical trials and furthering our blockchain & SSI roadmap. Traction in this domain will directly drive the future success of $TRL in the following ways: 1. New clinical trial contracts trigger our $TRL token economics (more info); 2. New clinical trial contracts trigger our $TRL burn accelerator (more info); 3. New clinical trial contracts (and associated customers) ensure the sustainability of Triall and thereby $TRL; 4. Our blockchain & SSI roadmap is one of our core USPs and continues to attract industry stakeholders such as Mayo Clinic who express interest in partnering, co-development, and other synergies. Our SSI applications will be instrumental in realising the decentralised and patient-centric data exchange environment that we are planning for, and in which $TRL will have broad utility. Now to answer your questions: ⁃ Software solutions are well-received and praised by clinical operations professionals for their intuitiveness, flexibility, and interoperability (being able to conduct all of your clinical trial activities in one single platform is one of our key strengths). We continue to further develop and strengthen our collaboration with Crucial Data Solutions, Sphereon, Mayo Clinic, and other strategic partners to extend upon our current offering and find new ways to collaborate and engage with our target customer groups. ⁃ $TRL is one of the key building blocks of our vision, which is building towards a federated data ecosystem where patients (and healthy volunteers) can provide and monetise their health data. As explained above, Triall and $TRL know several interdependencies where success in the clinical domain leads to success in the crypto domain (and vice versa). We intend to further engage and collaborate with the $TRL community across 2023, for instance by involving community members in sales and marketing activities. ⁃ While we won’t speculate on token price, we will continue to build traction in sales, marketing, and product development to benefit Triall and $TRL. Examples include strategic partnerships, media coverage, and product updates. We’ve also planned to publish a new public roadmap this quarter. We think it makes sense to fully dedicate our next AMA session to $TRL-related questions. To facilitate community input I’ve already opened up the question portal here: Kind regards, The Triall Team